CORCEPT THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Corcept Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Corcept Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was $35.6M, a 20.3% increase year-over-year.
  • Corcept Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $128M, a 29.4% increase year-over-year.
  • Corcept Therapeutics Inc annual Operating Income (Loss) for 2023 was $107M, a 4.75% decline from 2022.
  • Corcept Therapeutics Inc annual Operating Income (Loss) for 2022 was $113M, a 9.51% decline from 2021.
  • Corcept Therapeutics Inc annual Operating Income (Loss) for 2021 was $124M, a 2.91% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $128M $35.6M +$6.01M +20.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $122M $29.5M +$14.6M +98.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $107M $31.7M +$9.17M +40.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $98.1M $31.2M -$757K -2.37% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $98.9M $29.6M -$1.85M -5.88% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $101M $14.9M -$11.9M -44.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $113M $22.5M -$14.2M -38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $127M $31.9M -$4.3M -11.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $131M $31.4M -$511K -1.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $132M $26.8M +$7.13M +36.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $124M $36.7M +$6.15M +20.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $118M $36.2M +$11.5M +46.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $107M $31.9M -$3.32M -9.41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $110M $19.6M -$18.1M -47.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $128M $30.5M -$4.5M -12.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $133M $24.7M -$8.29M -25.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $141M $35.3M +$10.6M +43.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $130M $37.7M +$18.8M +98.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $112M $35M +$10.1M +40.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 $101M $33M +$10M +43.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $91.5M $24.6M +$4M +19.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $87.5M $19M -$2.04M -9.71% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $89.5M $24.9M +$3.2M +14.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $86.3M $23M +$9.35M +68.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $76.9M $20.6M +$7.84M +61.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $69.1M $21M +$16.3M +343% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $52.9M $21.7M +$16.7M +333% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $36.2M $13.6M +$10.6M +343% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $25.6M $12.8M +$11.3M +748% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $14.3M $4.74M +$4.15M +701% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $10.2M $5.01M +$3.36M +203% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $6.82M $3.07M +$2.97M +2912% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $3.85M $1.51M +$2.67M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $1.18M $592K +$4.62M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$3.44M $1.65M +$4.73M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 -$8.17M $102K +$5.21M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 -$13.4M -$1.17M +$5.42M +82.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$18.8M -$4.03M +$8.83M +68.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$27.6M -$3.08M +$6.95M +69.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 -$34.6M -$5.1M +$4.64M +47.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$39.2M -$6.58M +$4.2M +39% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$43.4M -$12.9M -$1.92M -17.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$41.5M -$10M -$50K -0.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$41.4M -$9.74M -$2.07M -27% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$39.4M -$10.8M -$3.19M -42% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$36.2M -$10.9M +$86K +0.78% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$36.3M -$9.98M -$52K -0.52% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 -$36.2M -$7.67M -$1.23M -19.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$35M -$7.59M +$1.28M +14.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$36.3M -$11M -$3.93M -55.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$32.3M -$9.93M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$6.44M +$668K +9.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$8.87M -$2.42M -37.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$7.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$7.11M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$6.45M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.